Syncona Shs GBP (GB:SYNC) has released an update. Syncona’s portfolio company, Autolus Therapeutics, has received FDA approval for AUCATZYL®, a ...

The agency reviewed data from the FELIX trial, in which 63 percent of patients achieved a complete remission on the cell therapy at any time point.

Obecabtagene autoleucel (obe-cel; Aucatzyl) has been approved by the FDA to treat patients with relapsed or refractory B-cell ...

The U.S. FDA has approved Autolus Therapeutics' Aucatzyl (obecabtagene autoleucel), a CD19-directed genetically modified ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

The immune system and especially the B cells of patients with acute lymphoblastic leukemia (ALL) is severely compromised following withdrawal from therapy, according to a new study. However, 6 months ...

Oct 21 (Reuters) - Former Hollywood producer Harvey Weinstein has chronic myeloid leukemia (CML), NBC News reported on Monday, citing sources. Weinstein is currently undergoing treatment for CML ...

(AP Photo/Abdel Kareem Hana) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] UNITED NATIONS (AP) — More than 1 billion people in the world live in acute poverty, over half are ...

More than one billion people live in acute poverty, with nearly half of them in countries experiencing conflict, according to a new United Nations report. Countries at war have higher levels of ...

Acute anemia can develop due to a rapid drop in red blood cells (RBCs) after losing blood. The more blood a person loses, the more severe the anemia becomes. It usually occurs due to hemorrhage or ...